Grant: CIHR Fellowship
University of Calgary
$90,000.00
Developing a dementia risk index derived from administrative healthcare databases to facilitate Alzheimer's disease and dementia drug discovery
FY 2022-23
Summary
Alzheimer's disease and other forms of dementia affect an increasing number of older adults in Canada. Current treatments for dementia provide only limited benefits for people affected by dementia. There is growing interest in evaluating the potential use of medications currently approved by Health Canada to treat conditions other than dementia as potential treatments to prevent or delay the onset of dementia. The concept of using currently available medications for new health conditions has been referred to as drug repurposing. Several types of medications used to treat other health conditions may also slow the progress of Alzheimer's disease or dementia. Early evidence suggests these medications could be "repurposed" as treatments to prevent or treat dementia. Given that these medications are frequently prescribed to individuals at risk of developing dementia, there is an opportunity to examine the "real-world evidence" for these non-dementia medications as potential dementia treatments using routinely collected health data. Potential medication classes that may be target for drug repurposing include different types of medications used to treat depression and epilepsy. Information on how different patterns of medication use may be related to changes in the risk of dementia may provide new information about the causes of dementia and identify potential treatments that could be evaluated in clinical trials. Our project will use population-based administrative healthcare databases in Alberta to develop a dementia risk index based on known risk factors for dementia. We will then examine how different medications used in the treatment of depression are associated with differences in the rates of dementia development as an example of drug repurposing. This dementia risk index will make it easier to find new ways to treat dementia in the future. This will be done by looking at how exposure to commonly prescribed medications might change the predicted risk of dementia.
Department
Program
CIHR Fellowship
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
471883
Name
Chowdhury Mohammad Z
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Developing a dementia risk index derived from administrative healthcare databases to facilitate Alzheimer's disease and dementia drug discovery
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Dementia; Drug Repurposing; Prediction Model; Risk Index
Abstract
Alzheimer's disease and other forms of dementia affect an increasing number of older adults in Canada. Current treatments for dementia provide only limited benefits for people affected by dementia. There is growing interest in evaluating the potential use of medications currently approved by Health Canada to treat conditions other than dementia as potential treatments to prevent or delay the onset of dementia. The concept of using currently available medications for new health conditions has been referred to as drug repurposing. Several types of medications used to treat other health conditions may also slow the progress of Alzheimer's disease or dementia. Early evidence suggests these medications could be "repurposed" as treatments to prevent or treat dementia. Given that these medications are frequently prescribed to individuals at risk of developing dementia, there is an opportunity to examine the "real-world evidence" for these non-dementia medications as potential dementia treatments using routinely collected health data. Potential medication classes that may be target for drug repurposing include different types of medications used to treat depression and epilepsy. Information on how different patterns of medication use may be related to changes in the risk of dementia may provide new information about the causes of dementia and identify potential treatments that could be evaluated in clinical trials. Our project will use population-based administrative healthcare databases in Alberta to develop a dementia risk index based on known risk factors for dementia. We will then examine how different medications used in the treatment of depression are associated with differences in the rates of dementia development as an example of drug repurposing. This dementia risk index will make it easier to find new ways to treat dementia in the future. This will be done by looking at how exposure to commonly prescribed medications might change the predicted risk of dementia.
Competitiondate
202210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chowdhury, Mohammad Z
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~